Michael Berk

107.2k total citations · 25 hit papers
1.4k papers, 68.2k citations indexed

About

Michael Berk is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Clinical Psychology. According to data from OpenAlex, Michael Berk has authored 1.4k papers receiving a total of 68.2k indexed citations (citations by other indexed papers that have themselves been cited), including 605 papers in Psychiatry and Mental health, 282 papers in Biological Psychiatry and 256 papers in Clinical Psychology. Recurrent topics in Michael Berk's work include Bipolar Disorder and Treatment (439 papers), Tryptophan and brain disorders (282 papers) and Schizophrenia research and treatment (220 papers). Michael Berk is often cited by papers focused on Bipolar Disorder and Treatment (439 papers), Tryptophan and brain disorders (282 papers) and Schizophrenia research and treatment (220 papers). Michael Berk collaborates with scholars based in Australia, United States and Brazil. Michael Berk's co-authors include Michaël Maes, Felice N. Jacka, Olivia Dean, Seetal Dodd, Julie A. Pasco, Gin S. Malhi, Lana J. Williams, Eduard Vieta, Gerwyn Morris and Adrienne O’Neil and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Michael Berk

1.3k papers receiving 66.4k citations

Hit Papers

Bipolar disorder 1991 2026 2002 2014 2015 2013 2010 2010 2008 250 500 750 1000

Peers

Michael Berk
Comparison fields: 5 of 225
  • Psychiatry and Mental health 22.7k
  • Biological Psychiatry 15.9k
  • Clinical Psychology 10.0k
  • Molecular Biology 9.4k
  • Physiology 8.4k
Replace Michaël Maes with:
Michaël Maes Thailand
Brenda W.J.H. Penninx Netherlands
Charles B. Nemeroff United States
Roger S. McIntyre Canada
J. John Mann United States
John H. Krystal United States
Maurizio Fava United States
A. John Rush United States
Carmine M. Pariante United Kingdom
George P. Chrousos Greece
Michaël Maes Thailand View profile →
Citations per field, relative to Michael Berk
Michael Berk · 1×
Citations per year, relative to Michael Berk
Michael Berk · 1×

Countries citing papers authored by Michael Berk

Since Specialization
Citations

This map shows the geographic impact of Michael Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Berk more than expected).

Fields of papers citing papers by Michael Berk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Berk. The network helps show where Michael Berk may publish in the future.

Co-authorship network of co-authors of Michael Berk

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Berk. A scholar is included among the top collaborators of Michael Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Berk. Michael Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 0
3 0
4 0
5 6
6 0
7 0
8 3
9 2
10 7
11 10
12 16
13 7
14
Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors breakdown →
149
15
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress breakdown →
190
16
Should antipsychotic medication always be given for first-episode psychosis?
2
17
Improvement of schizophrenia negative and positive symptoms with memantine as add-on therapy to clozapine: a double-blind, randomized, placebo-controlled trial
1
18
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics : a double-blind, randomised, placebo-controlled clinical trial
1
19
Seasonal influences on first episode admission in affective and non-affective psychosis
1
20
N-acetyl-cysteine treatment inhibits depletion of brain glutathione levels in rats : implications for schizophrenia
8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026